THE SYMBOL “[*]” INDICATES MATERIAL WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
ITURAN STOCKHOLDERS AGREEMENT
This Stockholders Agreement (this “Agreement”) is dated and effective as of September 13th, 2018 among Ituran Location and Control Limited, a company organized under the laws of the State of Israel of 3 Hashikma Street, Azour, Israel (“Ituran”), I-Gelt Holdings, LLC, a Georgia limited liability company (“I-Gelt”), East Holdings, LLC a Georgia limited liability company (“East”), Viatka Investments SL, a company organized in Spain (“Viatka”) and Yomuna Investments SL, a company organized in Spain (“Yomuna” and collectively with I-Gelt, East and Viatka, the “Shareholders”). Each of Ituran and the Shareholders are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
RECITALS
WHEREAS, Ituran and the Shareholders are parties to a Share Purchase Agreement dated as of July 23, 2018 (the “Purchase Agreement”), pursuant to which Ituran acquired certain securities of RTH from the Shareholders in exchange for cash and the Transaction Shares (as defined below);
WHEREAS, the transactions contemplated by the Purchase Agreement have been consummated as of the date of this Agreement and, pursuant to the Purchase Agreement, Ituran delivered to the Shareholders an aggregate of 373,489 Ituran Shares (collectively, the “Transaction Shares”), representing approximately _______% of the total outstanding Ituran Shares as of immediately following the consummation of the transactions contemplated by the Purchase Agreement;
WHEREAS, the Parties are entering into this Agreement for the purposes of setting forth their agreement and understanding relating to the ownership of the Transaction Shares by the Shareholder and certain other matters; and
WHEREAS, the execution and delivery of this Agreement is a condition to the obligations of the Parties to consummate the transactions contemplated by the Purchase Agreement.
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and their respective representations, warranties, covenants and agreements set forth in this Agreement, and intending to be legally bound hereby, the Parties agree as follows:
ARTICLE 1
Definitions
Section 1.1. Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings set forth in this Section 1.1:
“Activist Investor” means, as of any date, any Person that has, directly or indirectly through its publicly disclosed Affiliates, whether individually or as a member of a publicly disclosed Group, within the two (2) year period immediately preceding such date, and in each case with respect to Ituran, any of its Subsidiaries or any of its or their equity securities (i) publicly made, engaged in or been a participant (as defined in Instruction 3 to Item 4 of Schedule 14A under the Exchange Act) in any “solicitation” of “proxies” (as such terms are defined in Regulation 14A as promulgated by the SEC and assuming for this purpose only that Ituran was subject to the proxy rules under Section 14 of the Exchange Act) or in the submission of position statements (as such term is used in the Israeli Companies Law) (including, in each case, similar concepts under Israeli law), to vote any equity securities of Ituran or any of its Subsidiaries, including in connection with a proposed change in Control or other extraordinary or fundamental transaction involving Ituran or any of its Subsidiaries, or a public proposal for the election or replacement of any directors of Ituran or any of its Subsidiaries, not approved by the Board of Directors prior to first public disclosure thereof, (ii) publicly called, or publicly sought to call, a meeting of shareholders of Ituran or any of its Subsidiaries or publicly initiated any shareholder proposal or meeting agenda item for action by shareholders of Ituran or any of its Subsidiaries (including through action by written consent), in each case not approved by the Board of Directors prior to first public disclosure thereof, (iii) commenced a “tender offer” (as such term is used in Regulation 14D under the Exchange Act or in the Israeli Companies Law) to acquire equity securities of Ituran or any of its Subsidiaries that was not approved (at or before the time of commencement) by the Board of Directors, (iv) otherwise publicly acted, alone or in concert with others, to seek to Control or influence the Board of Directors or shareholders of Ituran or any of its Subsidiaries (provided that this clause (iv) is not intended to apply to the activities of any member of the Board of Directors, with respect to Ituran or such Subsidiary, taken in good faith solely in his or her capacity as a director of Ituran or such Subsidiary) or (v) publicly disclosed any intention, plan, arrangement or other Contract to do any of the foregoing.
“Affiliate” has the meaning as defined in the Purchase Agreement.
“Base Prospectus” means the prospectus in the form in which it appeared in the Registration Statement.
“Beneficially Own”, “Beneficial Owner” and “Beneficial Ownership” mean, with respect to any securities, having “beneficial ownership” of such securities for purposes of Rule 13d-3 or 13d-5 under the Exchange Act (as in effect on the date of this Agreement). In addition, a Person shall be deemed to be the Beneficial Owner of, and shall be deemed to Beneficially Own and have Beneficial Ownership of, any securities which are the subject of, or the reference securities for, or that underlie, any Derivative Instrument of such Person, with the number of securities Beneficially Owned being the notional or other number of securities specified in the documentation evidencing the Derivative Instrument as being subject to be acquired upon the exercise or settlement of such Derivative Instrument or as the basis upon which the value or settlement amount of such Derivative Instrument is to be calculated in whole or in part or, if no such number of securities is specified in such documentation, as determined by the Board of Directors in its sole discretion to be the number of securities to which the Derivative Instrument relates.
“Board of Directors” means the board of directors of Ituran.
“Business Day” has the meaning as defined in the Purchase Agreement.
“Change in Control” means the transfer in any manner, including by way of merger, consolidation or sale, of the assets or securities of Ituran such that Control of Ituran is transferred.
“Closing” has the meaning as defined in the Purchase Agreement.
“Contract” means any contract, agreement, instrument, undertaking, indenture, commitment, loan, license, settlement, consent, note or other legally binding obligation (whether or not in writing).
“Control”, “Controlled” and “Controlling” mean, when used with respect to any specified Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by Contract or otherwise, and the terms “Controlled by” and “under common Control with” shall be construed accordingly.
“Controlling Person” means a “controlling person” within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act.
“Current Directors” means directors serving on the Board of Directors as of the date of this Agreement.
“Derivative Instrument” means any and all derivative securities (as defined under Rule 16a-1 under the Exchange Act) that increase in value as the value of any Equity Securities of Ituran increases, including a long convertible security, a long call option and a short put option position, in each case, regardless of whether (a) such derivative security conveys any voting rights in any Equity Security, (b) such derivative security is required to be, or is capable of being, settled through delivery of any Equity Security or (c) other transactions hedge the value of such derivative security.
“Effectiveness Period” means the period commencing on the date hereof and continuing until the third (3rd) anniversary of the date hereof, provided the Effectiveness Period shall terminate on the date when all Registrable Securities held by the Shareholders (together with any Affiliates of any of the Shareholders with whom any of such Shareholders must aggregate sales under Rule 144) may be sold freely to the public under Rule 144.
“Equity Right” means, with respect to any Person, any security (including any debt security or hybrid debt-equity security) or obligation convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, or any options, calls, warrants, restricted shares, restricted shares units, deferred share awards, share units, “phantom” awards, dividend equivalents, participations, interests, rights or commitments relating to, or any share appreciation right or other instrument the value of which is determined in whole or in part by reference to the market price or value of, shares of capital stock or earnings of such Person.
“Equity Securities” means (a) Ituran Shares or other capital stock or equity interests or equity-linked interests of Ituran and (b) Equity Rights that are directly or indirectly exercisable or exchangeable for or convertible into Ituran Shares, or other capital stock or equity interests or equity-linked interests of Ituran.
“Exchange Act” means the United States Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder.
“Group” has the meaning assigned to such term in Section 13(d)(3) of the Exchange Act.
“Group Member” means, with respect to any specified Person, any Affiliate of the specified Person that is, directly or indirectly, Controlled by the specified Person and includes any Person with respect to which the specified Person is a direct or indirect Subsidiary.
“Hedging Arrangement” means any transaction or arrangement, including through the creation, purchase or sale of any security, including any security-based swap, swap, cash-settled option, forward sale agreement, exchangeable note, total return swap or other derivative, in each case, the effect of which is to hedge the risk of owning Equity Securities.
“Incumbent Directors” means (a) the Current Directors, (b) new directors nominated or appointed by a majority of the Current Directors, (c) directors appointed pursuant to recommendation of the Current Directors, and (d) other directors nominated or appointed by a majority of the Current Directors and other Incumbent Directors.
“Israeli Companies Law” means the Israeli Companies Law, 5759-1999, as amended from time to time, including regulations thereunder and successor provisions and regulations thereto.
“Ituran Competitor” means those competitors of Ituran identified on Schedule I to this Agreement and any successor thereto, acquirer thereof or acquirer of a material competing portion of the business thereof.
“Ituran Shares” has the meaning as defined in the Purchase Agreement.
“Law” has the meaning as defined in the Purchase Agreement.
“Organizational Documents” has the meaning as defined in the Purchase Agreement.
“Permitted Transferee” means the Shareholders and any direct or indirect Affiliate of a Shareholder.
“Person” has the meaning as defined in the Purchase Agreement.
“Prohibited Transferee” means (a) any Ituran Competitor, (b) any Activist Investor or (c) any Person who after such Transfer, would Beneficially Own more than 5% (five percent) of the Voting Securities and to the knowledge of the Shareholder, after due inquiry on the date of the applicable Transfer, would report its ownership position on Schedule 13D (or successor form).
“Prospectus” means the final prospectus supplement (including the Base Prospectus as so supplemented) relating to the resale of the Transaction Shares included in the Registration Statement in accordance with the rules and regulations promulgated under the Securities Act.
“Registrable Securities” means (a) the Transaction Shares, and (b) any Equity Securities issued or issuable with respect to any Transaction Shares by way of a stock dividend or stock split or in exchange for or upon conversion of such shares or otherwise in connection with a combination of shares, distribution, recapitalization, merger, consolidation, other reorganization or other similar event with respect to the Ituran Shares (it being understood that, for purposes of this Agreement, a Person shall be deemed to be a holder of Registrable Securities whenever such Person has the right to then acquire or obtain from Ituran any Registrable Securities, whether or not such acquisition has actually been effected). As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when (i) the SEC has declared a Registration Statement covering such securities effective and such securities have been disposed of pursuant to such effective Registration Statement, (ii) such securities are sold under circumstances in which all of the applicable conditions of Rule 144 under the Securities Act are met, (iii) such securities are otherwise transferred, or (iv) such securities cease to be outstanding.
“Registration Statement” means the registration statement on Form F-3 under the Securities Act to be filed with the SEC by Ituran in connection with the Closing on or about the date of Closing containing the Prospectus to be used by the Shareholders in connection with resales of their Registrable Securities in the manner described therein and includes the Prospectus and the documents incorporated by reference therein.
“Representatives” has the meaning as defined in the Purchase Agreement.
“Required Holders” means Shareholders holding at least a majority in interest of the applicable Registrable Securities.
“Restricted Period” means the period ending at the earlier of third anniversary following the Closing and a Change in Control.
“RTH” means Road Track Holding S.L., a company incorporated in Spain.
“Rule 144” means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.
“Rule 405” means Rule 405 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.
“SEC” has the meaning as defined in the Purchase Agreement.
“Securities Act” has the meaning as defined in the Purchase Agreement.
“Security Interest” has the meaning as defined in the Purchase Agreement.
“Subsidiary” means, with respect to a specified Person, any corporation or other Person of which securities or other interests having the power to elect a majority of that corporation’s or other Person’s board of directors or similar governing body, or otherwise having the power to direct the business and policies of that corporation or other Person (other than securities or other interests having such power only upon the happening of a contingency that has not occurred) are held by the specified Person or one or more of its Subsidiaries.
“Transfer” means the sale, assignment, pledge, lien, hypothecate or other obligations regarding the future sale, assignment, pledge or transfer of Beneficial Ownership of the Transaction Shares in any single transaction or series of related transactions.
“Voting Securities” means the Ituran Shares.
Section 1.2. Additional Defined Terms. For purposes of this Agreement, the following terms have the meanings specified in the indicated Section of this Agreement:
Defined Term | | Section |
| | |
Agreement | | Preamble |
Ituran | | Preamble |
Legal Counsel | | Section 2.3(b) |
Parties | | Preamble |
Purchase Agreement | | Recitals |
Shareholders | | Preamble |
Transaction Shares | | Recitals |
Viatka | | Preamble |
Yomuna | | Preamble |
Section 1.3. Construction. Unless expressly specified otherwise, whenever used in this Agreement, the terms “Article,” “Exhibit,” “Schedule” and “Section” refer to articles, exhibits, schedules and sections of this Agreement. Whenever used in this Agreement, the terms “hereby,” “hereof,” “herein” and “hereunder” and words of similar import refer to this Agreement as a whole, including all articles, sections, schedules and exhibits hereto. Whenever used in this Agreement, the terms “include,” “includes” and “including” mean “include, without limitation,” “includes, without limitation” and “including, without limitation,” respectively. Whenever the context of this Agreement permits, the masculine, feminine or neuter gender, and the singular or plural number, are each deemed to include the others. The word “or” is not exclusive. “Days” means calendar days unless otherwise specified. Unless expressly specified otherwise, all payments to be made in accordance with or under this Agreement shall be made in U.S. Dollars (USD$). References in this Agreement to particular sections of a Law shall be deemed to refer to such sections or provisions as they may be amended after the date of this Agreement. The Parties have participated jointly in the negotiation and drafting of this Agreement and in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party (or any Affiliate thereof) by virtue of the authorship of any of the provisions of this Agreement.
ARTICLE 2
Registration and Transfer Restrictions
Section 2.1. Ituran Representations and Warranties. Ituran warrants and represents that:
(a) The Transaction Shares have been issued in compliance with all laws, rules and regulations, including applicable securities laws and the Organizational Documents of Ituran. The Transaction Shares were issued clean and free of any Security Interest or any restrictions on resale other than as set forth in this Agreement.
(b) The Transaction Shares are free of restrictions on Transfer other than as set forth in this Agreement.
Section 2.2. Registration Statement. Ituran agrees, represents and warrants as follows:
(a) Ituran has prepared and filed or shall use its reasonable best efforts to prepare and, as soon as practicable after the date hereof, file with the SEC a Registration Statement on Form F-3 covering the resale of all of the Registrable Securities. The Registration Statement prepared pursuant hereto shall register for resale all of the Registrable Securities. Ituran shall use its reasonable best efforts to have the Registration Statement declared effective by the SEC as soon as practicable and shall file with the SEC in accordance with Rule 424 under the Securities Act the Prospectus to be used in connection with sales pursuant to the Registration Statement.
(b) At the time the Registration Statement and any amendments thereto become effective, the Registration Statement and any supplements and amendments thereto will conform in all material respects to the requirements of the Securities Act and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto is issued, will conform in all material respects to the requirements of the Securities Act and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
(c) Ituran has not, in the twelve (12) months preceding the date hereof, received notice from any trading market on which the Ituran Shares is or have been listed or quoted to the effect that Ituran is not in compliance with the listing or maintenance requirements of such trading market. Ituran is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
(d) Ituran shall use its reasonable best efforts to maintain the effectiveness of the Registration Statement during the Effectiveness Period.
(e) In the event that Form F-3 is not available for the registration of the resale of the Registrable Securities hereunder or Ituran is not eligible to use Form F-3 to register the Registrable Securities for resale under applicable SEC rules and regulations, then, Ituran shall (i) register the resale of the Registrable Securities on Form F-1 or another appropriate SEC form that Ituran is then eligible to use which is reasonably acceptable to the Required Holders and (ii) undertake to register the Registrable Securities on Form F-3 as promptly as reasonably practicable after Ituran becomes eligible to us such form; provided, however, that the Ituran shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form F-3 covering all of the Registrable Securities has been declared effective by the SEC, or if earlier, until the end of the Effectiveness Period (as defined in Section 3(a)).
Section 2.3. Registration Procedures. Ituran shall use its reasonable best efforts to maintain the registration of the offer and sale of the Registrable Securities under the Securities Act in accordance with the intended method of disposition thereof, and pursuant thereto Ituran shall as soon as practicable and as applicable:
(a) prepare and file with the SEC such amendments, post-effective amendments and supplements to the Registration Statement and the Prospectus used in connection therewith as may be necessary to keep the Registration Statement effective for the Effectiveness Period);
(b) within a reasonable time before filing amendments or supplements to the Registration Statement and the Prospectus used in connection therewith with the SEC, furnish to one (1) counsel selected by the Required Holders (“Legal Counsel”), which the Shareholders agree shall be Hahn & Hessen LLP or such other counsel as thereafter designated in writing by the Required Holders, copies of such documents proposed to be filed, which documents shall be subject to the review and comment of Legal Counsel;
(c) notify each selling holder of Registrable Securities, promptly after Ituran receives notice thereof, of the time when a supplement to any Prospectus forming a part of the Registration Statement has been filed with the SEC; it being understood and agreed that Ituran may provide such notice by providing a website url link to the applicable SEC filing;
(d) furnish to each selling holder of Registrable Securities such number of copies of the Prospectus included in the Registration Statement (including each preliminary Prospectus) and any supplement thereto (in each case including all exhibits and documents incorporated by reference therein), and such other documents as such seller may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such seller; it being understood and agreed that Ituran may satisfy such requirement by providing such selling holder a website url link with the applicable SEC filing;
(e) use its reasonable best efforts to register or qualify the Registrable Securities under such other securities or “blue sky” laws of such jurisdictions as are required by applicable state securities laws at the time of resale of Registrable Securities prior to the end of the Effectiveness Period; provided, that Ituran shall not be required to qualify generally to do business, subject itself to general taxation or consent to general service of process in any jurisdiction where it would not otherwise be required to do so but for this Section 2.3(e);
(f) notify each selling holder of the Registrable Securities, at any time when a Prospectus relating thereto is required to be delivered under the Securities Act, of the occurrence of any event that would cause the Prospectus included in the Registration Statement to contain an untrue statement of a material fact or omit any fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading, and, at the request of any such holder, Ituran shall prepare a supplement or amendment to such Prospectus so that, as thereafter delivered to the purchasers of the applicable Registrable Securities, such Prospectus shall not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading;
(g) in connection with an underwritten offering of Registrable Securities, enter into such customary agreements (including underwriting and lock-up agreements in customary form) and take all such other customary actions as the holders of such Registrable Securities or the managing underwriter(s) of such offering reasonably request in order to expedite or facilitate the disposition of such Registrable Securities (including, without limitation, making appropriate officers of Ituran available to participate in “road show” and other customary marketing activities (including reasonable requests for one-on-one meetings with prospective purchasers of such Registrable Securities));
(h) otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC and make available to its stockholders an earnings statement (in a form that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 under the Securities Act or any successor rule thereto) no later than thirty (30) days after the end of the 12-month period beginning with the first day of Ituran’s first full fiscal quarter after the effective date of the Registration Statement, which earnings statement shall cover said 12-month period, and which requirement will be deemed to be satisfied if Ituran timely files complete and accurate information on Forms 20-F and 6-F under the Exchange Act and otherwise complies with Rule 158 under the Securities Act or any successor rule thereto;
(i) furnish to each underwriter, if any, with (i) a written legal opinion of Ituran’s outside counsel, dated the closing date of the offering, in form and substance as is customarily given in opinions of Ituran’s counsel to underwriters in underwritten SEC registered offerings; and (ii) on the date of the applicable Prospectus, on the effective date of any post-effective amendment to the applicable Registration Statement and at the closing of the offering, dated the respective dates of delivery thereof, a “comfort” letter signed by Ituran’s independent certified public accountants in form and substance as is customarily given in accountants’ letters to underwriters in underwritten registered offerings;
(j) advise the holders of Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the SEC suspending the effectiveness of the Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal at the earliest possible moment if such stop order should be issued;
(k) take no direct or indirect action prohibited by Regulation M under the Exchange Act; provided, that, to the extent that any prohibition is applicable to Ituran, Ituran will take all reasonable action to make any such prohibition inapplicable; and
(l) otherwise use its reasonable best efforts to take all other steps necessary to maintain the effectiveness of the registration of the Registrable Securities contemplated hereby until the end of the Effective Period.
Section 2.4. Restrictions on Transfer. (a) The right of the Shareholders and their respective Affiliates to Transfer directly or indirectly in any single transaction or series of related transactions any of the Transaction Shares is subject to the restrictions set forth in this Section 2.4, and no Transfer of Transaction Shares by the Shareholders or any of their respective Affiliates may be effected except in compliance with this Section 2.4. Any attempted Transfer in violation of this Agreement shall be of no effect and null and void, regardless of whether the purported Transferee has any actual or constructive knowledge of the Transfer restrictions set forth in this Agreement, and shall not be recorded on the stock transfer books of Ituran or any local custodian or transfer agent.
(b) A Shareholder shall not directly or indirectly, in any single transaction or series of related transactions, Transfer any of the Transaction Shares during the Restricted Period either (x) to a Prohibited Transferee or (y) without the prior written consent of Ituran other than:
(i) a Transfer of the Transaction Shares in response to a tender or exchange offer by any Person that has been approved or recommended by the Board of Directors (provided a majority of directors at the time of such approval or recommendation are Incumbent Directors);
(ii) a Transfer of the Transaction Shares to Ituran or an Affiliate of Ituran;
(iii) a Transfer of the Transaction Shares to a Permitted Transferee, so long as such Permitted Transferee, to the extent it has not already done so, executes a customary joinder to this Agreement, in form and substance reasonably acceptable to Ituran, in which such Permitted Transferee agrees to be bound by the terms of this Agreement as if such Permitted Transferee was an original party hereto;
provided, in each case, that any such Transfer is made in accordance with all applicable Laws; and provided further, that, notwithstanding the foregoing, the Shareholder shall be entitled at any time during the Restricted Period to request that Ituran waive, in whole or in part, the restrictions of this Section 2.4(b), and Ituran will consider such request in good faith and shall not unreasonably delay its response to such request or refuse such request.
(c) Following the Restricted Period, the Shareholder shall be entitled to Transfer any Shares in its sole discretion.
(d) A Shareholder shall not be deemed to have breached its obligations under Section 2.4(b) as it relates to Activist Investors with respect to the Transfer of Transaction Shares to any Person so long as such Shareholder acts in good faith, based on generally available public information and the advice of its financial advisors, to determine whether such Person is an Activist Investor. The reporting by a Person of its ownership of the securities of Ituran on Schedule 13G shall be deemed to establish conclusively that such Person is not an Activist Investor with respect to Ituran for purposes of the definition of “Activist Investor”, except to the extent such Person subsequently files a Schedule 13D with respect to Ituran.
(e) A Shareholder shall not Transfer, or cause or permit the Transfer of, any Shares in connection with any “tender offer” (as such term is used in Regulation 14D under the Exchange Act or the Israeli Companies Law) not approved or recommended by the Board of Directors (provided a majority of directors at the time of such approval or recommendation are Incumbent Directors).
(f) The entry by the Shareholder into a Hedging Arrangement with respect to Shares shall not be deemed to be a Transfer of such Shares for purposes of this Agreement.
(g) A Shareholder shall not be deemed to have breached its obligations under Section 2.4(b) as it relates to any Prohibited Transferee with respect to the Transfer of Transaction Shares in transactions described in Rule 144(f)(1) or (2).
Section 2.5. Reporting. Ituran agrees to use its reasonable best efforts to:
(a) make and keep public information available, as those terms are understood and defined in Rule 144; and
(b) file with the SEC, in a timely manner, all reports and other documents required of Ituran under the Exchange Act.
Section 2.6. Indemnification.
(a) Ituran shall indemnify and hold harmless, to the fullest extent permitted by law, each holder of Registrable Securities, such holder’s officers, directors, managers, and each other Controlling Person, if any, who controls any of the foregoing Persons, against all losses, claims, actions, damages, liabilities and expenses, joint or several, to which any of the foregoing Persons may become subject under the Securities Act or otherwise, insofar as such losses, claims, actions, damages, liabilities or expenses arise out of or are based upon any untrue or alleged untrue statement of a material fact contained in the Registration Statement, Prospectus, preliminary Prospectus, free writing prospectus (as defined in Rule 405 under the Securities Act or any successor rule thereto) or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or free writing prospectus, in light of the circumstances under which they were made) not misleading; and shall reimburse such Persons for any legal or other expenses reasonably incurred by any of them in connection with investigating or defending any such loss, claim, action, damage or liability, except insofar as the same are caused by or contained in any information furnished in writing to Ituran by such holder expressly for use therein or by such holder’s failure to deliver a copy of the Registration Statement, Prospectus, preliminary Prospectus, free writing prospectus (as defined in Rule 405) or any amendments or supplements thereto (if the same was required by applicable law to be so delivered) after Ituran has furnished such holder with a sufficient number of copies of the same prior to any written confirmation of the sale of Registrable Securities. This indemnity shall be in addition to any liability Ituran may otherwise have. Ituran further agrees to provide customary indemnification to any underwriter, broker or any other Person acting on behalf of a holder of Registrable Securities in any agreement executed in connection with the retention of such underwriter, broker, or other Person for an offering subject to registration hereunder.
(b) In connection with any registration in which a holder of Registrable Securities is participating, each such holder shall furnish to Ituran in writing such information as Ituran reasonably requests for use in connection with any the Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify and hold harmless, Ituran, each director of Ituran, each officer of Ituran who shall sign the Registration Statement, and each Controlling Person who controls any of the foregoing Persons against any losses, claims, actions, damages, liabilities or expenses resulting from any untrue or alleged untrue statement of material fact contained in the Registration Statement, Prospectus, preliminary Prospectus, free writing prospectus (as defined in Rule 405 under the Securities Act or any successor rule thereto) or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or free writing prospectus, in light of the circumstances under which they were made) not misleading, but only to the extent that such untrue statement or omission is contained in any information so furnished in writing by such holder expressly for use therein; provided, that the obligation to indemnify shall be several, not joint and several, for each holder and shall not exceed an amount equal to the net proceeds (after underwriting fees, commissions or discounts) actually received by such holder from the sale of Registrable Securities pursuant to the Registration Statement. This indemnity shall be in addition to any liability the selling holder may otherwise have.
(c) Promptly after receipt by an indemnified party of notice of the commencement of any action involving a claim referred to in this Section 2.6, such indemnified party shall, if a claim in respect thereof is made against an indemnifying party, give written notice to the latter of the commencement of such action. The failure of any indemnified party to notify an indemnifying party of any such action shall not (unless such failure shall have a material adverse effect on the indemnifying party) relieve the indemnifying party from any liability in respect of such action that it may have to such indemnified party hereunder. In case any such action is brought against an indemnified party, the indemnifying party shall be entitled to participate in and to assume the defense of the claims in any such action that are subject or potentially subject to indemnification hereunder, jointly with any other indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such indemnified party, and after written notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be responsible for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof; provided, that, if (i) any indemnified party shall have reasonably concluded that there may be one or more legal or equitable defenses available to such indemnified party which are additional to or conflict with those available to the indemnifying party, or that such claim or litigation involves or could have an effect upon matters beyond the scope of the indemnity provided hereunder, or (ii) such action seeks an injunction or equitable relief against any indemnified party or involves actual or alleged criminal activity, the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party without such indemnified party’s prior written consent (but, without such consent, shall have the right to participate therein with counsel of its choice) and such indemnifying party shall reimburse such indemnified party and any Controlling Person of such indemnified party for that portion of the fees and expenses of any counsel retained by the indemnified party which is reasonably related to the matters covered by the indemnity provided hereunder. If the indemnifying party is not entitled to, or elects not to, assume the defense of a claim, it shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. In such instance, the conflicting indemnified parties shall have a right to retain one separate counsel, chosen by the holders of a majority of the Registrable Securities included in the registration, at the expense of the indemnifying party.
(d) If the indemnification provided for hereunder is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, claim, damage, liability or action referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amounts paid or payable by such indemnified party as a result of such loss, claim, damage, liability or action in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions which resulted in such loss, claim, damage, liability or action as well as any other relevant equitable considerations; provided, that the maximum amount of liability in respect of such contribution shall be limited, in the case of each holder of Registrable Securities, to an amount equal to the net proceeds (after underwriting fees, commissions or discounts) actually received by such seller from the sale of Registrable Securities effected pursuant to such registration. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party, whether the violation of the Securities Act or any other similar federal or state securities laws or rule or regulation promulgated thereunder applicable to Ituran and relating to action or inaction required of Ituran in connection with any applicable registration, qualification or compliance was perpetrated by the indemnifying party or the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties agree that it would not be just and equitable if contribution pursuant hereto were determined by pro rata allocation or by any other method or allocation which does not take account of the equitable considerations referred to herein. No Person guilty or liable of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
ARTICLE 3
Voting
Section 3.1. Voting Agreement.
(a) During the Restricted Period, each Shareholder shall cause all of the Voting Securities Beneficially Owned at the time of a vote by it or any of its Group Members or over which it or any of its Group Members has voting control to be voted (i) in favor of all those persons nominated and recommended to serve as directors of Ituran by the Board of Directors or any applicable committee thereof, and (ii) with respect to any other action, proposal or matter to be voted on by the shareholders of Ituran (including through action by written consent), in accordance with the recommendation of the Board of Directors or any applicable committee thereof (so long as a majority of directors at the time of such recommendation are Incumbent Directors). Notwithstanding the foregoing, any Shareholder or Group Member shall be free to vote at its discretion in connection with any proposal submitted for a vote of the shareholders of Ituran in respect of (A) the issuance of Equity Securities in connection with any merger, consolidation or business combination of Ituran, (B) any merger, consolidation or business combination of Ituran or (C) the sale of all or substantially all the assets of Ituran, except in each of clause (A), (B) and (C) where such proposal has not been approved or recommended by the Board of Directors, in which event the preceding sentence shall apply.
(b) During the Restricted Period, with respect to any matter that any of the Shareholders is required to vote on in accordance with Section 3.1(a), each Shareholder shall cause each Voting Security owned by it or over which it has voting control to be voted by completing the proxy forms distributed by Ituran and not by any other means. The Shareholder shall deliver the completed proxy form to Ituran no later than five (5) Business Days prior to the date of such general meeting of Ituran. Upon the written request of Ituran, the Shareholder hereby agrees to take such further action or execute such other instruments as may be reasonably necessary to effectuate the intent of this Section 3.1(b).
ARTICLE 4
Standstill
Section 4.1. During the Restricted Period, any Shareholder shall not, directly or indirectly, and shall cause its Representatives (to the extent acting on behalf of the Shareholder) and Group Members not, directly or indirectly, to, without the prior written consent of, or waiver by, Ituran:
(a) subject to Section 4.2, acquire, offer or seek to acquire, agree to acquire or make a proposal (including any private proposal to Ituran or the Board of Directors) to acquire, by purchase or otherwise (including through the acquisition of Beneficial Ownership), any securities (including any Equity Securities or Voting Securities) or Derivative Instruments, or direct or indirect rights to acquire any securities (including any Equity Securities or Voting Securities) or Derivative Instruments, of Ituran or any Subsidiary or Affiliate of Ituran (other than RTH or any of its Subsidiaries in accordance with other Transaction Documents as defined in the Purchase Agreement) or any successor to or Person in Control of Ituran, or any securities (including any Equity Securities or Voting Securities) or indebtedness convertible into or exchangeable for any such securities or indebtedness; provided that the Shareholder may acquire, offer or seek to acquire, agree to acquire or make a proposal to acquire Equity Securities (and any securities (including any Equity Securities or Voting Securities) convertible into or exchangeable for Equity Securities) and Derivative Instruments with respect to Ituran Shares, if, immediately following such acquisition, the collective Beneficial Ownership of Ituran Shares of the Shareholder and its Group Members, as a group, would not exceed 4.99% of the outstanding Ituran Shares, as reported to the SEC;
(b) offer, or seek to acquire, or participate in any acquisition of a majority of the consolidated assets of Ituran and its Subsidiaries, taken as a whole;
(c) conduct, fund or otherwise become a participant in any “tender offer” (as such term is used in Regulation 14D under the Exchange Act or the Israeli Companies Law) involving Equity Securities, Voting Securities or any securities convertible into, or exercisable or exchangeable for, Equity Securities or Voting Securities, in each case not approved by the Board of Directors;
(d) otherwise act in concert with others to seek to control or influence the Board of Directors or shareholders of Ituran or its Subsidiaries or Affiliates; provided that nothing in this Section 4.1 shall preclude the Shareholder or its Representatives from engaging in discussions with Ituran or its Representatives or exercising its rights under the Purchase Agreement or other Transaction Documents (as defined in the Purchase Agreement);
(e) make or join or become a participant (as defined in Instruction 3 to Item 4 of Schedule 14A under the Exchange Act) in (or in any way knowingly encourage) any “solicitation” of “proxies” (as such terms are defined in Regulation 14A as promulgated by the SEC and assuming for this purpose only that Ituran was subject to the proxy rules under Section 14 of the Exchange Act) (including, in each case, similar concepts under Israeli law, including submission of positions statements), or consent to vote any Voting Securities or any of the voting securities of any Subsidiaries or Affiliates of Ituran (including through action by written consent), or otherwise knowingly advise or influence any Person with respect to the voting of any securities of Ituran or its Subsidiaries or Affiliates;
(f) make any public announcement with respect to, or solicit or submit a proposal for, or offer, seek, propose or indicate an interest in (with or without conditions) any merger, consolidation, business combination, “tender offer” (as such term is used in Regulation 14D under the Exchange Act or the Israeli Companies Law), recapitalization, reorganization, purchase or license of a material portion of the assets, properties, securities or indebtedness of Ituran or any Subsidiary or Affiliate of Ituran, or other similar extraordinary transaction involving Ituran, any Subsidiary of Ituran or any of its securities or indebtedness, or enter into any discussions, negotiations, arrangements, understandings or agreements (whether written or oral) with any other Person regarding any of the foregoing;
(g) call or seek to call a meeting of shareholders of Ituran or initiate any shareholder proposal or meeting agenda item for action of Ituran’s shareholders, or seek election or appointment to or to place a representative on the Board of Directors or seek the removal of any director from the Board of Directors;
(h) form, join, become a member or in any way participate in a Group with respect to the securities of Ituran or any of its Subsidiaries or Affiliates, other than with the other Shareholders and their respective Affiliates;
(i) deposit any Voting Securities in a voting trust or similar Contract or subject any Voting Securities to any voting agreement, pooling arrangement or similar arrangement or Contract, or grant any proxy with respect to any Voting Securities (in each case, other than with the Shareholder or any of its wholly owned Subsidiaries);
(j) make any proposal or disclose any plan, or cause or authorize any of its and their directors, officers, employees, agents, advisors and other Representatives to make any proposal or disclose any plan on its or their behalf, inconsistent with the foregoing restrictions;
(k) knowingly take any action or cause or authorize any of its and their directors, officers, employees, agents, advisors and other Representatives to take any action on its or their behalf, that would reasonably be expected to require Ituran or any of its Subsidiaries or Affiliates to publicly disclose any of the foregoing actions or the possibility of a business combination, merger or other type of transaction or matter described in this Section 4.1;
(l) knowingly advise, assist, arrange or otherwise enter into any discussions or arrangements with any third party with respect to any of the foregoing; or
(m) directly or indirectly, contest the validity of, any provision of this Section 4.1 (including this sub clause) or Section 3.1 (whether by legal action or otherwise).
Section 4.2. The prohibition in Section 4.1(a) shall not apply to the activities of the Shareholder or any of its Group Members in connection with:
(a) acquisitions made as a result of a stock split, stock dividend, reorganization, recapitalization, reclassification, combination, exchange of shares or other like change approved or recommended by the Board of Directors; or
(b) acquisitions made in connection with a transaction or series of related transactions in which the Shareholder or any of its Group Members acquires a previously unaffiliated business entity that Beneficially Owns Equity Securities, Voting Securities or Derivative Instruments, or any securities convertible into, or exercisable or exchangeable for, Equity Securities, Voting Securities or Derivative Instruments, at the time of the consummation of such acquisition, provided that in connection with any such acquisition, (i) the Shareholder or such applicable Group Member, as the case may be, either (A) causes such entity to divest the Equity Securities, Voting Securities or Derivative Instruments, or any securities convertible into, or exercisable or exchangeable for, Equity Securities, Voting Securities or Derivative Instruments, Beneficially Owned by the acquired entity within a period of one hundred twenty (120) calendar days after the date of the consummation of such acquisition or (B) divests the Equity Securities, Voting Securities or Derivative Instruments, or any other securities convertible into, or exercisable or exchangeable for, Equity Securities, Voting Securities or Derivative Instruments, Beneficially Owned by the Shareholder and its Permitted Transferees, in an amount so that the Shareholder and its Permitted Transferees, together with such acquired business entity, shall not, acting alone or as part of a Group, directly or indirectly, Beneficially Own a number of Ituran Shares in excess of 4.99% of Ituran’s outstanding capital following such acquisition, and (ii) prior to the disposition thereof, such Equity Securities or other Voting Securities remain subject to the terms of this Agreement in all respects.
Section 4.3. Ituran acknowledges and agrees that no Shareholder shall be deemed an affiliate (as that term is defined in Rule 144(a)) of Ituran during the term of this Agreement.
ARTICLE 5
Miscellaneous
Section 5.1. Fees and Expenses. Except as otherwise provided in this Agreement or the Purchase Agreement, each Party shall pay its own direct and indirect expenses incurred by it in connection with the preparation and negotiation of this Agreement and the consummation of the transactions contemplated by this Agreement, including all fees and expenses of its advisors and representatives.
Section 5.2. Notices. All notices and other communications in connection with this Agreement shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service, by facsimile, pdf or other electronic transmission (with receipt confirmed) or by registered or certified mail (postage prepaid, return receipt requested) to the respective Parties at the following addresses:
If to Ituran, to:
ITURAN LOCATION AND CONTROL LTD.
3 Hashikma Street
Azour, Israel
Fax: +972-3-5571393
Attn: Guy Aharonov, Adv., VP Legal
Email: guy_a@ituran.com
with a copy (which shall not constitute notice) to:
Yoram L. Cohen, Law Offices
23 Bar Kochva St.
B’nei-Brak 5126002
Israel
Fax: +972-3-6490340
Attn: Yoram L. Cohen, Adv.
Email: yoram@ylc-law.co.il
If to a Shareholder, to the address set forth on Annex A
with a copy (which shall not constitute notice) to:
Hahn & Hessen LLP
488 Madison Avenue
New York, NY 10022
United States
Fax: 212.478.7400
Attn: James Kardon, Esq.
Email: jkardon@hahnhessen.com
Any Party may, by delivery of written notice to the other Parties, change the address to which such notices and other communications are to be given in connection with this Agreement.
Section 5.3. Counterparts; Entire Agreement; Corporate Power; Facsimile Signatures. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement. The Escrow Agreement, this Agreement, the other Transaction Documents and the Schedules hereto contain the entire agreement between the Parties with respect to the subject matter hereof, supersede all previous agreements, negotiations, discussions, writings, understandings, commitments and conversations with respect to such subject matter and there are no agreements or understandings between the Parties other than those set forth or referred to herein or therein. Each Party acknowledges that it and the other Parties may execute this Agreement by manual, stamp or mechanical signature, and that delivery of an executed counterpart of a signature page to this Agreement (whether executed by manual, stamp or mechanical signature) by facsimile or by email in portable document format (PDF) shall be effective as delivery of such executed counterpart of this Agreement. Each Party expressly adopts and confirms a stamp or mechanical signature (regardless of whether delivered in person, by mail, by courier, by facsimile or by email in portable document format (PDF)) made in its respective name as if it were a manual signature delivered in person, agrees that it shall not assert that any such signature or delivery is not adequate to bind such Party to the same extent as if it were signed manually and delivered in person and agrees that, at the reasonable request of the other Party at any time, it shall as promptly as reasonably practicable cause this Agreement to be manually executed (any such execution to be as of the date of the initial date thereof) and delivered in person, by mail or by courier.
Section 5.4. Amendments and Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by Ituran and the Shareholders or, in the case of a waiver, by the Party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any Party to exercise any right hereunder in any manner impair the exercise of any such right.
Section 5.5. Successors and Assigns. Subject to clauses (b) and (c) below, this Agreement shall be binding upon the Parties and their respective successors and assigns and shall inure to the benefit of the Parties and their respective successors and permitted assigns.
(a) Ituran may not assign or delegate this Agreement or any rights or obligations hereunder without the prior written consent of the Shareholders; provided that no such consent shall be required for any assignment by Ituran of its rights or obligations hereunder in connection with a merger, consolidation, combination, reorganization or similar transaction or the transfer, sale, lease, conveyance or disposition of all or substantially all of its assets.
(b) The Shareholders may not assign or delegate this Agreement or any rights or obligations hereunder without the prior written consent of Ituran; provided that no such consent shall be required for (i) subject to Section 5.5(d), any assignment by any of the Shareholders of its rights or obligations hereunder in connection with a merger, consolidation, combination, reorganization or similar transaction or the transfer, sale, lease, conveyance or disposition of all or substantially all of its assets, if such assignee agrees in writing to be bound by the terms of this Agreement or (ii) the assignment or delegation by any of the Shareholders of any of its rights or obligations under this Agreement to an Affiliate, if such Affiliate agrees in writing to be bound by the terms of this Agreement and shall together with the Shareholder and any prior Affiliate Transferee shall be deemed the Shareholder; provided further that no such assignment or delegation shall relieve the Shareholder of its obligations under this Agreement.
(c) Except as provided in Section 5.5(d), the covenants and agreements of the Shareholders set forth in this Agreement shall not be binding upon or restrict any Transferee of Shares other than (i) Permitted Transferees or (ii) any Transferee of Shares pursuant to a Transfer in connection with which the Shareholder’s rights under this Agreement are assigned to the Transferee pursuant to Section 5.5(b)(i), and no Transferee of Shares other than such Permitted Transferees or a transferee of the Shareholder’s rights pursuant to Section 5.5(b)(i) shall have any rights under this Agreement.
(d) A Shareholder shall not enter into any transaction pursuant to which any Person, other than its current ultimate parent entity, would become its ultimate parent entity (such that the Shareholder is a direct or indirect Subsidiary of another Person or all or substantially all of the Shareholder’s assets have been acquired by another Person) without causing such Person to assume all of the Shareholder’s obligations under this Agreement effective as of the consummation of such transaction.
Section 5.6. Acknowledgment of Securities Laws. Each Party is aware, and shall advise its Representatives who are informed of the matters that are the subject of this Agreement, of the restrictions imposed by the securities laws of the United States on the purchase or sale of securities by any Person who has received material, nonpublic information from the issuer of such securities and on the communication of such information to any other person when it is reasonably foreseeable that such other person is likely to purchase or sell such securities in reliance upon such information.
Section 5.7. Termination. This Agreement (except for Section 2.6, Section 4.3 and Article 5) shall terminate at the earlier of (a) the mutual written agreement of Ituran and the Shareholders and (b) a Change in Control.
Section 5.8. No Third Party Beneficiaries. This Agreement is intended for the benefit of the Parties and their respective successors and permitted assigns.
Section 5.9. Severability. In the event that any one or more of the terms or provisions of this Agreement or the application thereof to any Person or circumstance is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement, or the application of such term or provision to Persons or circumstances or in jurisdictions other than those as to which it has been determined to be invalid, illegal or unenforceable, and the Parties shall use their commercially reasonable efforts to substitute one or more valid, legal and enforceable terms or provisions into this Agreement which, insofar as practicable, implement the purposes and intent of the Parties. Any term or provision of this Agreement held invalid or unenforceable only in part, degree or within certain jurisdictions shall remain in full force and effect to the extent not held invalid or unenforceable to the extent consistent with the intent of the Parties as reflected by this Agreement. To the extent permitted by applicable Law, each Party waives any term or provision of Law which renders any term or provision of this Agreement to be invalid, illegal or unenforceable in any respect.
Section 5.10. Business Days. If the last or appointed day for the taking of any action or the expiration of any right required or granted in this Agreement is not a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.
Section 5.11. Governing Law and Venue; Waiver of Jury Trial.
(a) THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE SUBSTANTIVE AND PROCEDURAL LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO ITS RULES OF CONFLICTS OF LAW. The Parties irrevocably submit to the exclusive jurisdiction of the courts of the State of New York located in the City of New York, Borough of Manhattan and the federal courts of the United States of America for the Southern District with respect to all matters arising out of or relating to this Agreement and the interpretation and enforcement of the provisions of this Agreement, and of the documents referred to in this Agreement, and in respect of the transactions contemplated by this Agreement, and waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement hereof or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in such courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the Parties agree that all claims with respect to such action or proceeding shall be heard and determined exclusively in such a New York state or federal court. The Parties agree that a final judgment in any such any action, suit or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. The Parties consent to and grant any such court jurisdiction over the person of such Parties solely for such purpose and over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 5.2 or in such other manner as may be permitted by Law shall be valid and sufficient service.
(b) EACH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY ACKNOWLEDGES AND AGREES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER. EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER. EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS IN THIS SECTION 6.10(b).
Section 5.12. Enforcement. The Parties acknowledge and agree that irreparable damage would occur in the event that any provision of this Agreement was not performed in accordance with its specific terms or was otherwise breached, and that monetary damages, even if available, would not be an adequate remedy therefor. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the performance of the terms and provisions hereof in any court referred to in Section 5.11, without proof of actual damages (and each Party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are entitled at Law or in equity. The Parties further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for such breach.
Section 5.13. Obligations Several. The obligations of each Shareholder hereunder is several, not joint, and in no event shall any Shareholder be liable or responsible for any breach of this Agreement by another Shareholder.
Section 5.14. Escrow. The Transaction Shares will be deposited with Wells Fargo Bank, National Association acting as escrow agent pursuant to the Escrow Agreement.
Section 5.15. Legal Counsel. (b) Ituran shall bear the reasonable expenses of Legal Counsel’s review under Section 2.3(b).
(b) The Shareholders hereby waive any conflict of interest or potential conflict of interest that may arise as a result of the representation of such Investors by Hahn & Hessen LLP in connection with the subject matter of this Agreement. This provision will not prohibit any other counsel to a Shareholder from reviewing and commenting on any registration filed pursuant to this Agreement at no cost to Ituran.
[Signature pages follow]
IN WITNESS WHEREOF, Ituran and the Shareholders have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date first above written.
| Ituran:
ITURAN LOCATION AND CONTROL LTD.
By:_______________________________________ Name: Title:
The Shareholders:
YOMUNA INVESTMENTS SL By:_______________________________________ Name: Title: VIATKA INVESTMENTS SL By:_______________________________________ Name: Title: I-GELT HOLDINGS, LLC By:_______________________________________ Name: Title: EAST HOLDINGS, LLC By:_______________________________________ Name: Title: |
Schedule 1
Ituran Competitors
American Tracer
AutoTrack
FleetBoss
FleetMatics
G4S
GPS Insight
Guide Point
I-Metrik SVR
ISR
LoJack Corporation
Megatrans S.A
Navtrack
Network Fleet
OnStar Corporation
PassTime
Pointer
Position Plus
Prosegur
Sascar
Sitrac S.A.
Sky Cop
Sky Guard
Sky Patrol
Skylock Ltd.
Spireon (which also includes SysLocate and GoldStar)
Street Eagle
Teletrac
Traffilog
Trim Track
Trimble
Ubicar S.A.
Zatix
Schedule 1 - 1